BNP PARIBAS FINANCIAL MARKETS - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 201 filers reported holding CANTEL MEDICAL CORP in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$735,646,000
+2.0%
9,214
+0.8%
0.00%0.0%
Q4 2020$721,175,000
+183.1%
9,145
+57.7%
0.00%
Q3 2020$254,764,000
-95.7%
5,798
-95.7%
0.00%
-100.0%
Q2 2020$5,909,482,000
+8238.8%
133,608
+6668.4%
0.01%
Q1 2020$70,867,000
-72.4%
1,974
-45.5%
0.00%
Q4 2019$256,587,000
-42.4%
3,619
-39.2%
0.00%
-100.0%
Q3 2019$445,135,000
+455.9%
5,951
+499.3%
0.00%
Q2 2019$80,076,000
-6.3%
993
-22.3%
0.00%
Q1 2019$85,485,000
+91.1%
1,278
+112.6%
0.00%
Q4 2018$44,744,000
-88.2%
601
-85.4%
0.00%
-100.0%
Q3 2018$378,090,000
+4.7%
4,107
+11.8%
0.00%0.0%
Q2 2018$361,177,000
-68.1%
3,672
-63.9%
0.00%
-50.0%
Q1 2018$1,131,703,000
-26.2%
10,158
-31.9%
0.00%
-33.3%
Q4 2017$1,534,203,000
-13.1%
14,914
-20.5%
0.00%
-25.0%
Q3 2017$1,766,441,000
+93.7%
18,758
+60.3%
0.00%
+33.3%
Q2 2017$911,781,000
+50.4%
11,703
+54.7%
0.00%
+50.0%
Q1 2017$606,037,000
+14.2%
7,566
+12.3%
0.00%0.0%
Q4 2016$530,460,000
+22.8%
6,736
+21.6%
0.00%0.0%
Q3 2016$431,931,000
-44.0%
5,539
-50.7%
0.00%
-33.3%
Q2 2016$771,700,000
+108.8%
11,228
+116.8%
0.00%
+50.0%
Q1 2016$369,502,000
-10.7%
5,178
-22.3%
0.00%
+100.0%
Q4 2015$413,852,000
+3.6%
6,660
-5.5%
0.00%0.0%
Q3 2015$399,508,000
+160.5%
7,046
+146.5%
0.00%
Q2 2015$153,389,000
+301.6%
2,858
+255.5%
0.00%
Q1 2015$38,190,000
-45.4%
804
-60.5%
0.00%
Q3 2014$69,998,000
+764.9%
2,036
+821.3%
0.00%
Q2 2014$8,093,000
+137.0%
221
+114.6%
0.00%
Q1 2014$3,415,000
-77.8%
103
-77.3%
0.00%
Q4 2013$15,395,000
-94.7%
454
-95.0%
0.00%
Q3 2013$289,198,000
+12.3%
9,080
+19.4%
0.00%
Q2 2013$257,547,0007,6040.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q3 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders